2026 Specialty Measure Set

2026 MIPS Quality Measures for Allergy/Immunology

The 12 MIPS quality measures designated by CMS for the Allergy/Immunology specialty set. These are the measures allergy/immunology specialists are most likely to report on, though any MIPS-eligible measure can be submitted.

12measures
9high priority
12with benchmarks
7topped out
ID ↑Measure eCQMType Status
MIPS 130Documentation of Current Medications in the Medical RecordCMS68v15High PriorityTopped Out
MIPS 226Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionCMS138v14ProcessTopped Out
MIPS 238Use of High-Risk Medications in Older AdultsCMS156v14High PriorityTopped Out
MIPS 317Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedCMS22v14ProcessTopped Out
MIPS 331Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)—High PriorityBenchmark
MIPS 332Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)—High PriorityTopped Out
MIPS 338HIV Viral SuppressionCMS314v3High PriorityTopped Out
MIPS 340HIV Annual Retention in CareCMS1157v2High PriorityBenchmark
MIPS 374Closing the Referral Loop: Receipt of Specialist ReportCMS50v14High PriorityTopped Out
MIPS 398Optimal Asthma Control—High PriorityBenchmark
MIPS 493Adult Immunization Status—ProcessBenchmark
MIPS 503Gains in Patient Activation Measure (PAM) Scores at 12 Months—High PriorityBenchmark

All Specialty Sets

Need help selecting measures?

VBCA's clinical policy team helps practices choose the right measure mix based on patient population, benchmark opportunity, and program requirements.

Get a measure-mix review →